Public Law 110-85

E651087

Public Law 110-85 is a 2007 U.S. federal statute that significantly expanded the Food and Drug Administration’s authority over drug and medical device safety, post-market surveillance, and user fees.

Try in SPARQL Jump to: Statements Referenced by

Statements (46)

Predicate Object
instanceOf Act of Congress
United States federal statute
aimsTo enhance medical device safety oversight
improve drug safety monitoring
increase transparency of clinical trials
amends Federal Food, Drug, and Cosmetic Act NERFINISHED
Public Health Service Act NERFINISHED
authorizes Risk Evaluation and Mitigation Strategies NERFINISHED
authorizesAppropriationsFor Food and Drug Administration NERFINISHED
concerns medical device user fees
prescription drug user fees
creates Pediatric Medical Device Safety and Improvement Act provisions NERFINISHED
establishes Food and Drug Administration Amendments Act Risk Evaluation and Mitigation Strategies authority NERFINISHED
expandsAuthorityOf Food and Drug Administration NERFINISHED
hasAbbreviation FDAAA NERFINISHED
hasCongress 110
hasCountry United States of America
surface form: United States
hasEnactmentDate 2007-09-27
hasPublicLawNumber P.L. 110-85 NERFINISHED
hasSectionOn active surveillance systems for drug safety
labeling changes for safety reasons
pediatric device tracking and incentives
post-market risk management
hasShortTitle FDA Amendments Act of 2007 NERFINISHED
hasStatutesAtLargeCitation 121 Stat. 823
hasTitle Food and Drug Administration Amendments Act of 2007 NERFINISHED
hasType public law
includes pediatric research and drug study provisions
isPartOf United States food and drug law NERFINISHED
jurisdiction United States of America
surface form: United States
language English
reauthorizes Medical Device User Fee and Modernization Act NERFINISHED
Prescription Drug User Fee Act NERFINISHED
regulates Food and Drug Administration NERFINISHED
medical devices
prescription drugs
requires clinical trial registration and results reporting on ClinicalTrials.gov
enhanced post-marketing drug safety studies
strengthens FDA post-market safety authorities
subject drug safety
medical device safety
post-market surveillance
user fees for drugs and medical devices
wasEnactedBy 110th United States Congress NERFINISHED
wasSignedBy George W. Bush NERFINISHED
yearOfEnactment 2007

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.